B-cell lymphoma 2 inhibitor venetoclax treatment of a patient with cutaneous T-cell lymphoma - Amber Loren O. King, BA; Fatima N. Mirza, MPH; Julia M. Lewis, PhD; Kacie R. Carlson, PA; Scott Huntington, MD, MPH; Francine M. Foss, MD; Michael Girardi, MD (JAAD Case Reports, 2021)